Industry Trends

Peptide Serialization and Track and Trace Compliance Guide

Peptide Serialization and Track and Trace Compliance Guide
A
Amanda Foster
|||8 min read

Counterfeit drugs cause more than one million deaths globally every year. Peptide serialization and track and trace systems are one of the most effective tools for stopping fake drugs from reaching patients.

The Drug Supply Chain Security Act, or DSCSA, now requires full interoperable tracing for prescription drugs in the US. For peptide manufacturers and distributors, compliance is not optional.

🔑Key Takeaway

  • DSCSA requires electronic tracing of prescription drug packages unit by unit
  • Full interoperability requirements took full effect in 2026
  • Every saleable unit needs a unique serialized identifier
  • Track and trace systems protect patients from counterfeit or diverted drugs
  • Non-compliance can result in FDA warning letters and supply chain disruption

What Is Peptide Serialization

Serialization is the process of assigning a unique identifier to each drug package unit. For peptides, this means every vial, syringe, or bottle gets a code that is its own identity in the supply chain.

The identifier is usually a 2D barcode or RFID tag. It contains data such as the product code, lot number, expiration date, and serial number.

What Is Track and Trace

Track and trace is the ability to follow a drug unit from the manufacturer all the way to the pharmacy or hospital. Every time the unit changes hands, the transfer is recorded.

"Track" means you can follow the drug in real time as it moves. "Trace" means you can look back and see where it has been.

The DSCSA and What It Requires

The Drug Supply Chain Security Act was signed into law in 2013. It created a 10-year roadmap for building a fully interoperable drug tracing system in the US.

The key requirements under DSCSA include:

  • Product Identification: Each package must have a standardized numerical identifier
  • Product Tracing: Trading partners must share transaction information electronically
  • Product Verification: The ability to verify the identity of a drug package at any point
  • Detection and Response: Systems to identify and respond to suspect or illegitimate products
  • Notification: Reporting to FDA when a suspect product is found

The 2026 Compliance Landscape

In 2026, the DSCSA interoperability requirements are fully in force. This means all trading partners in the supply chain must be able to exchange serialization data electronically and in a standard format.

Earlier phases allowed manual or hybrid methods. Full interoperability means your system must connect directly with your trading partners' systems.

DSCSA Milestone Year Requirement
Serialization for manufacturers 2017 Unit-level serial numbers
Repackager requirements 2018 Serialization for repackaged drugs
Wholesale distributor requirements 2019 Electronic transaction data
Dispenser requirements 2020 Accepting serialized products
Full interoperability 2026 Electronic, interoperable tracing

How Serialization Works in a Peptide Plant

Adding serialization to a peptide manufacturing line involves several key systems working together.

1. Serialization Software This generates unique serial numbers and manages the master data. It connects to your enterprise systems like ERP and MES.

2. Packaging Line Hardware Printers apply the 2D barcode or RFID label to each unit. Cameras verify that the code was applied correctly and is readable.

3. Aggregation Systems Aggregation links individual unit codes to the case or pallet they are packed into. This allows verification at multiple packaging levels.

4. Trading Partner Integration Your system must send and receive serialization data from customers, distributors, and logistics partners using standard formats like GS1 EPCIS.

Common Serialization Data Standards

The industry uses several data standards for serialization. Understanding them helps you buy the right systems.

Standard What It Does
GS1 SGTIN Unique product identifier combining company, product, and serial number
GS1 EPCIS Standard for sharing serialization and tracing events between trading partners
GS1 2D DataMatrix The barcode format used on drug packages
RFID/EPC Radio-frequency identification for higher-speed scanning
HL7 FHIR For sharing data with health system partners

Key Challenges in Peptide Serialization

Peptide manufacturers face some unique challenges when implementing serialization and track and trace.

High-Value, Low-Volume Products Many peptide drugs are high-value specialty products. Each unit is worth a lot, which makes anti-counterfeiting protection even more important. But low volumes can make it harder to justify large serialization infrastructure investments.

Cold Chain Complexity Many peptide drugs require refrigerated or frozen storage. Serialization equipment must work reliably in cold environments. Some barcode printers and scanners are not rated for cold conditions.

Short Expiration Dates Peptides often have shorter shelf lives than small molecules. Expiration date data must be accurately captured and communicated to prevent expired product from reaching patients.

Multiple Dosage Forms Peptide products may come in vials, prefilled syringes, autoinjectors, and oral forms. Each format needs different serialization hardware and label designs.

Steps to Build a Serialization Compliance Program

Getting serialization right requires a structured approach. Here are the key steps.

Step 1: Map Your Supply Chain Identify every point where product changes hands. This includes CMOs, 3PLs, distributors, and dispensers.

Step 2: Select Your Serialization Platform Choose software and hardware that supports GS1 standards and can integrate with your trading partners' systems. Major vendors include Antares Vision, TraceLink, and Serialized.

Step 3: Integrate with Trading Partners Test electronic data exchange with your key partners before go-live. This is where most implementation problems occur.

Step 4: Train Your Team Operators need to understand what to do if a barcode fails to scan or print. Quality teams need to know how to handle serialization exceptions.

Step 5: Validate Your System Like all GMP systems, your serialization platform must be validated. Document validation protocols, testing, and results.

Step 6: Monitor and Maintain Serialization systems need ongoing maintenance. Barcodes can degrade, software needs updates, and trading partner connections need monitoring.

What Happens If You Are Not Compliant

DSCSA non-compliance carries serious consequences for peptide companies.

  • FDA Warning Letters: The FDA can issue public warning letters for serialization failures
  • Import Alerts: Non-compliant foreign manufacturers may face import restrictions
  • Wholesale Distributor Rejection: Distributors may refuse to accept products that do not meet serialization requirements
  • Product Recalls: If tracing data is missing, it is harder to manage recalls efficiently
  • Reputational Damage: Compliance failures become public and can damage your brand

International Serialization Requirements

DSCSA is the US framework, but other markets have their own requirements.

Country/Region System Key Requirement
European Union EU Falsified Medicines Directive Serial number + anti-tampering device
China NMPA track and trace Barcode on every package
Russia MDLP system Electronic registration and tracing
Saudi Arabia SFDA track and trace Serialization + verification
Brazil ANVISA Track and trace for specific drug types

If you sell peptides internationally, your serialization system must be flexible enough to meet multiple regulatory requirements.

For guidance on supply chain compliance, explore our post on peptide supply chain risk management.

For official DSCSA requirements, visit the FDA Drug Supply Chain Security Act page.

FAQs

What is serialization in pharmaceutical manufacturing?

Serialization is assigning a unique identifier to each drug package unit. This code contains the product name, lot number, expiration date, and serial number. It allows the drug to be tracked individually through the supply chain.

What does DSCSA require for peptide companies?

DSCSA requires that all prescription drug manufacturers, repackagers, wholesale distributors, and dispensers assign unique serial numbers to products and share transaction data electronically with trading partners.

What is the deadline for DSCSA full interoperability?

Full interoperability requirements were phased in, with the final requirements taking effect in 2026. All trading partners in the US pharmaceutical supply chain must now be able to exchange serialization data electronically.

What is GS1 EPCIS?

GS1 EPCIS is a global standard for sharing supply chain events such as shipping, receiving, and dispensing. It is the standard format used for exchanging serialization data between trading partners under DSCSA.

How much does serialization cost for a small peptide company?

Implementation costs vary widely. A small company with one or two production lines might spend $500,000 to $2 million on serialization hardware, software, and integration. Ongoing annual costs for software licenses and maintenance typically run $100,000 to $300,000.

Can you outsource serialization compliance?

Yes. Some contract manufacturers and 3PLs offer serialization services. You can also work with specialized serialization technology vendors who handle implementation and ongoing management.

What happens if a barcode does not scan correctly?

Any package that cannot be verified must be held as a suspect product and investigated before it can be released. Your standard operating procedures must define how to handle serialization exceptions.

Topics

peptide serialization track traceDSCSA peptide compliancepharmaceutical serializationtrack and trace biotechsupply chain visibility peptides
AF

Amanda Foster

Peptide Industry Analyst

MS, Health Economics | 8 years in peptide market research

Tracks workforce trends, compensation data, and market dynamics across the peptide industry. Produces quarterly salary benchmarks and employer-of-record analysis cited by clinic operators nationwide.

Reviewed by Amanda Foster, MS, April 2026